Accelerate Diagnostics, Inc 3 SEC Filings

Filed On	Filing
25 Jun 2025	Form 3: Nathan Gilbert E, Director No securities owned
01 May 2025	Form 3: Shalhoub Paul Vincent, Director No securities owned
01 Jun 2023	Form 3: Regan Jennifer, Director No securities owned
01 Jun 2023	Form 3: Ogilvie Marran H., Director No securities owned
01 Jun 2023	Form 3: Black Mark S., Director No securities owned
04 Apr 2023	Form 3: Patience David, Chief Financial Officer Holds 47,471 shares of Common Stock
13 Jul 2022	Form 3: Mertz Larry Michael, Chief Technology Officer Holds 331,662 shares of Common Stock
08 Feb 2022	Form 3: Burris Wayne, Director No securities owned
24 May 2021	Form 3: Massarany Hany, Director No securities owned
27 Aug 2020	Form 3: Safwat Nedal, Chief Strategy Officer No securities owned
04 Dec 2019	Form 3: Francesconi Louise, Director No securities owned
14 Nov 2019	Form 3: Diggelmann Roland D, Director No securities owned
08 Aug 2019	Form 3: Phillips Jack, CHIEF OPERATING OFFICER No securities owned
07 Mar 2019	Form 3: Humphries Romney, CHIEF SCIENTIFIC OFFICER
28 Nov 2017	Form 3: Watts Charles M, Director No securities owned
23 Mar 2017	Form 3: Brown Thomas D, Director No securities owned
17 Mar 2017	Form 3: Price Ron, SVP & HEAD OF COM OPS AMERICAS
17 Mar 2017	Form 3: Martin Joan, EXECUTIVE VP AND HEAD OF EMEA Holds 40,250 shares of Common Stock
06 Nov 2013	Form 3: Bantock Pete, CHIEF COMMERCIAL OFFICER
05 Nov 2013	Form 3: Miller Mark C, Director No securities owned

Comments